$ 3.48
Key Takeaways
Risk factor
Very high price volatility
Profitability factor
Greatly undervalued vs peers
About
The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient stem cell transplants and transfusions programs, and patient support. The company also offers and manages clinical trial services, such as managing clinical trials, palliative care programs,...
Company Valuation
From both historical and forecast perspectives, the stock is considerably underpriced compared to similar stocks.
Target Price
The average target price of TOI is 7.2 and suggests 106% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increas
